首页> 外文期刊>感染症学雑誌 >新しい結核対策 国立感染症研究所ハンセン病研究センター
【24h】

新しい結核対策 国立感染症研究所ハンセン病研究センター

机译:新结核病对策汉森病研究中心国家感染研究中心

获取原文
获取原文并翻译 | 示例
           

摘要

The 1951 Tuberculosis Control Law of Japan was amended extensively and has been in effect since April, 2005. The revision of the National Tuberculosis Program (NTP) is to respond to the tremendous changes that have occurred during the last 50 years in tuberculosis epidemiology and in the environment in tuberculosis control implementation. In this review, the main points and framework of the revisions were summarized and the perspective of the development of new technical innovations relevant to each area of the revised TB control legislation is discussed. Also,challenges of Japan's NTP in the recent future are discussed,including the controversies over the proposed abolishment of the Tuberculosis Control Law,1.Immunization, In the revision of NTP,the BCG vaccination of elementary school and junior-high school entrants was discontinued. In order to strengthen the early primary vaccination for infants, the new Law has adopted the direct vaccination scheme omitting tuberculin testing prior to immunization. This program is implemented to young babies, i.e.less than six months old,as defined by the decree. It is a heavy responsibility for the municipalities to ensure the high coverage of immunization when the period of legal vaccination is rather strictly limited practically to the fourth to sixth months after birth.The safe direct vaccination is another new challenge where appropriate management of the Koch's phenomenon or similar reactions should be warranted.2Chemoprophylaxis,Though unfortunately suspended for some legal reason currently,the expansion and improvement of chemoprophylaxis,or treatment of latent tuberculosis infection, to cover anyone with higher risk of clinical development of TB would have a tremendous effect in Japan, especially since 90% of patients who developed TB were infected tens of years ago. The technical innovations in diagnosis of TB infection such as QuantiFERON will be very helpful, Development of new drugs or drug regimens for this purpose is also expected.3.Case detection. The "indiscriminate" screening scheme in the periodic mass health examination has been replaced with a selective one.Only subjects aged 65 or older are eligible for the screening, supplemented with selected occupational groups who are considered to become source of infection,should they develop tuberculosis,such as health-care providers and school teachers. Local autonomies are also responsible for offering screening to the socio-economic high-risk populations,such as homeless people,slum residents, day laborers,and/or workers in small businesses,as decided by the autonomies at their disposal. Another important mode of active case-finding,i,e, contact investigation has been legally enforced so that anybody cannot refuse to be examined by the Health Center. This investigation service will be greatly enhanced by such new technologies as DNA fingerprinting of TB bacilli and a new diagnostic of TB infection. Regarding the clinical service of the symptomatic patients that detect 75% of new cases currently will be improved in its quality by introducing an external quality assurance system of commercial bacteriological laboratory services.4.Treatment and patient support: The revised NTP clearly states the government's responsibility for treating TB patients in close cooperation with a doctor, in the framework of the DOTS Japan version. While the development of new anti-tuberculosis drugs will be realized in the near future, Japan still has to overcome the issues of improper practice of treatment, as well as the government's slow process for approving drugs to be used for multi-drug resistant TB and non-tuberculous mycobacterioses, such as quinolones,macrolides and others.5.Prefectural TB Control Plan:In order to respond to the specific issues of tuberculosis problem in the respective prefectures in terms of epidemiology or in available resources,the Law requests every prefecture to develop and implement its own TB control plan.The rath
机译:1951年日本结核病管制法在2005年4月以来一直在效果。国家结核病计划(NTP)的修订是响应在结核病流行病学的过去50年中发生的巨大变化结核病控制实施中的环境。在本次审查中,讨论了修订的主要观点和框架,并讨论了与经修订的TB控制立法的每个领域相关的新技术创新的视角。此外,还讨论了日本NTP的挑战,包括拟议废除结核病管制法的争议,1.imunization,在NTP的修订中,小学和初中进入者的BCG接种疫苗已停止。为了加强婴儿的早期主要疫苗接种,新法律采用直接疫苗接种方案省略结核蛋白检测。该计划用于幼婴儿,即六个月,由法令所定义。当时法律疫苗接种期间实际上严格限时到出生后第四至第六个月时,为确保免疫的高度覆盖是一个沉重的责任。安全直接疫苗接种是对科赫现象的适当管理的另一个新挑战或类似的反应应该有保证。虽然遗憾的是,暂停目前的一些法律原因,但抑制潜伏结核病感染的扩张和改善,以涵盖具有较高临床发育风险的临床开发风险的任何人在日本会产生巨大的效果特别是因为90%的发展结核病的患者被感染了数十年前。诊断TB感染的技术创新如Quantiferon将非常有帮助,为此目的的新药或药物方案的开发也是预期的.3。箱检测。定期大规模健康检查中的“不分青红皂白酸的”筛查方案已被选择性one.Only受试者替换为65岁或以上的受试者有资格筛选,补充有被认为成为感染来源的选定职业群体,如果它们发展结核病,如医疗保健提供者和学校教师。当地自主也负责向社会经济高风险人群提供筛选,例如无家可归的人,贫民窟居民,日劳动者和/或小企业的工人,这是由自身处置的自动化决定。在法律上强制执行,我,e,E,联系调查的另一个重要模式,即联系调查,以便任何人无法拒绝被健康中心审查。这种调查服务将通过这种新技术作为TB Bacilli的DNA指纹识别和Tb感染的新诊断。关于检测75%的症状患者的临床服务,目前将通过引入商业细菌学实验室服务的外部质量保证体系来提高其质量的提高.4。治疗和患者支持:修订的NTP明确规定了政府的责任在与医生密切合作的情况下,在DOTS日本版的框架中对抗患者。虽然新的抗结核药物的发展将在不久的将来实现,但是日本仍然必须克服不正当的治疗实践问题,以及政府批准药物用于多药物抗性结核病的缓慢过程非结核病的药杆菌,如喹诺酮,大啰拿硼和其他.5.PREFECTOULALITULATURTIONTIONATIONTIONTIONATIONT TB控制计划:为了在流行病学或现有资源方面响应各州的结核病问题的特定问题,法律要求每张州制定并实施自己的TB控制计划.Rath

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号